Home > Boards > US Listed > Telecommunications Hardware > ADC Telecommunications (ADCT)

Hi NW, Money's still with ADCT. I think

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
OldAIMGuy Member Profile
Member Level 
Followed By 113
Posts 14,280
Boards Moderated 6
Alias Born 01/29/02
160x600 placeholder
ADC Therapeutics nimmt an der Cantor Virtual Global Healthcare Conference 2021 teil Business Wire - 9/23/2021 4:39:00 PM
ADC Therapeutics participera à l’édition 2021 de la Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 8:44:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/23/2021 7:23:29 AM
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 7:15:00 AM
ADC Therapeutics erhält Orphan-Drug-Status in Europa für ZYNLONTA® Business Wire - 9/13/2021 9:36:00 PM
ADC Therapeutics a reçu la désignation de médicament orphelin en Europe pour ZYNLONTA® Business Wire - 9/13/2021 8:36:00 AM
ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA® Business Wire - 9/13/2021 7:15:00 AM
ADC Therapeutics participera à la 19e conférence annuelle mondiale sur les soins de santé de Morgan Stanley Business Wire - 9/9/2021 1:55:00 PM
ADC Therapeutics nimmt an der 19. jährlichen globalen Gesundheitskonferenz von Morgan Stanley teil Business Wire - 9/9/2021 8:47:00 AM
ADC Therapeutics to Participate in Morgan Stanley’s 19th Annual Global Healthcare Conference Business Wire - 9/9/2021 7:15:00 AM
ADC Therapeutics gibt Wechsel in der medizinischen Führungsspitze bekannt Business Wire - 9/3/2021 3:12:00 PM
ADC Therapeutics annonce une transition au niveau de sa direction médicale Business Wire - 9/3/2021 9:38:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:22:53 AM
ADC Therapeutics Announces Medical Leadership Transition Business Wire - 9/3/2021 7:15:00 AM
ADC Therapeutics schließt Finanzierungsvereinbarung mit HealthCare Royalty im Umfang von bis zu 325 Millionen US-Dollar ab Business Wire - 8/26/2021 7:05:00 PM
ADC Therapeutics conclut un accord de financement avec HealthCare Royalty pour un montant pouvant aller jusqu'à 325 millions USD Business Wire - 8/26/2021 3:42:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/26/2021 8:35:26 AM
ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million Business Wire - 8/26/2021 7:15:00 AM
ADC Therapeutics publie ses résultats financiers pour le deuxième trimestre 2021 et fait le point sur ses activités Business Wire - 8/4/2021 9:27:00 AM
ADC Therapeutics gibt Finanzergebnisse für das zweite Quartal 2021 und aktuelle Unternehmensentwicklungen bekannt Business Wire - 8/3/2021 11:13:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/3/2021 7:08:26 AM
ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates Business Wire - 8/3/2021 7:00:00 AM
ADC Therapeutics veranstaltet am 3. August 2021 eine Telefonkonferenz zu den Finanzergebnissen des 2. Quartals 2021 Business Wire - 7/29/2021 2:26:00 AM
ADC Therapeutics organise le 3 août 2021 une conférence téléphonique sur ses résultats financiers du deuxième trimestre 2021 Business Wire - 7/29/2021 2:26:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 7/28/2021 5:09:20 PM
OldAIMGuy Member Level  Wednesday, 03/20/02 07:18:42 PM
Re: NorthWesterner post# 4
Post # of 46 
Hi NW, Money's still with ADCT. I think ST it will respond more quickly to market changes because of its smaller size.

Best regards, Tom






Port Washington, WI 53074
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences